Midostaurin

Category: Cancer

Midostaurin Overview

Midostaurin, sold under the brand name Rydapt, is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.[1] Contents 1 AML and MDS 2 Systemic ma...

Read more Midostaurin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Midostaurin

Recent Midostaurin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Midostaurin or a similar ingredient: (1 result)

• RYDAPT Midostaurin